Search


Verastem Oncology's CEO comments on a volatile week and #ASCO24 data in pancreatic cancer
Dan Paterson gives background on the rolling submission the company started this week in a type of ovarian cancer, with his thoughts on...
Jun 1, 2024
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.